Can sodium bicarbonate (NaHCO₃) be given as a bolus to neonates (≤28 days old) with severe metabolic acidosis or cardiac arrest?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sodium Bicarbonate Bolus in Neonates: Not Recommended

Sodium bicarbonate should NOT be given as a bolus to neonates, and its use during neonatal resuscitation is no longer supported by current evidence. The 2025 International Liaison Committee on Resuscitation (ILCOR) has formally withdrawn its previous treatment recommendation for sodium bicarbonate in neonatal resuscitation 1.

Key Guideline Changes

The most critical update is that the prior 2005 treatment recommendation has been officially withdrawn 1. Previously, sodium bicarbonate was suggested for prolonged arrests after adequate ventilation was established with no response to other therapies. However, based on current evidence evaluation methods, ILCOR concluded there is neither direct nor indirect evidence to support any treatment recommendation for sodium bicarbonate in neonatal resuscitation 1.

Why the Recommendation Was Withdrawn

  • No new evidence supports its use in neonatal resuscitation 1
  • Animal studies (2-5 day old piglets) suggest potential mechanisms of harm, particularly when vasoconstrictors are co-administered 1
  • The conditions previously suggested for use are rare and unexpected in human infants needing immediate resuscitation 1

Specific Risks of Bolus Administration in Neonates

Rapid bolus injection poses severe dangers unique to neonates:

FDA-Labeled Warnings for Neonatal Use

The FDA drug label explicitly warns that rapid injection (10 mL/min) of hypertonic sodium bicarbonate in neonates and children under 2 years may produce 2:

  • Hypernatremia
  • Decreased cerebrospinal fluid pressure
  • Intracranial hemorrhage

The rate should be limited to no more than 8 mEq/kg/day, with a 4.2% solution preferred for slow administration 2.

Hemodynamic Instability

Research demonstrates that even when given slowly, sodium bicarbonate causes significant hemodynamic fluctuations in neonates 3, 4:

  • Rapid administration increases cerebral blood volume more dramatically than slow infusion 3
  • Transient increases in cardiac output (+27.7%) and blood pressure occur 4
  • These fluctuations in cerebral blood flow are particularly dangerous in preterm infants at risk for intracranial hemorrhage

Mechanisms of Harm

Multiple pathophysiologic mechanisms explain why sodium bicarbonate worsens outcomes 5:

  • Paradoxical intracellular acidosis: CO₂ generated from bicarbonate crosses cell membranes more readily than bicarbonate itself, worsening intramyocardial pH
  • Reduced oxygen delivery: Leftward shift of the oxyhemoglobin dissociation curve
  • Decreased coronary perfusion pressure
  • Hyperosmolar load: Solutions are hypertonic (1000 mOsm/L when diluted 1:1) 4

Clinical Evidence Shows No Benefit

A randomized controlled trial of 55 asphyxiated neonates found that sodium bicarbonate given during resuscitation did not change acid-base status in the first 24 hours of life 6. The number of babies with persistent metabolic acidosis at 1,6,12, and 24 hours was comparable between treatment and control groups 6.

Current Resuscitation Algorithm for Neonates

Focus on these priorities instead 1:

  1. Optimize ventilation - ensure adequate chest rise and effective positive pressure ventilation
  2. Effective chest compressions - if heart rate remains <60 bpm despite adequate ventilation
  3. Intravascular epinephrine (0.01-0.03 mg/kg) - if heart rate has not increased to ≥60/min after optimizing ventilation and compressions 1
  4. Volume expansion - if hypovolemia suspected

The Only Potential Exception

In emergencies such as cardiac arrest, the risk of rapid infusion must be weighed against the potential for fatality due to acidosis 2. However, even in this scenario:

  • The FDA acknowledges this is a risk-benefit decision in extremis
  • The 2025 ILCOR guidelines provide no support for this practice
  • No human neonatal data demonstrate benefit

Common Pitfalls to Avoid

  • Do not use sodium bicarbonate during brief CPR - it is discouraged and evidence suggests harm 1, 5
  • Do not give rapid boluses - if sodium bicarbonate must be used in older children/adults for specific indications (hyperkalemia, TCA overdose), neonates require much slower administration 2
  • Do not assume acidosis correction improves outcomes - the acidosis may be a marker of severity rather than a therapeutic target 7

Alternative Approaches for Metabolic Acidosis

If metabolic acidosis requires correction outside of resuscitation 8:

  • Acetate in parenteral nutrition for slow correction
  • Lactated Ringer's solution instead of saline for volume boluses
  • Oral citrate for chronic management
  • Address the underlying cause - this is the primary intervention

The evidence is clear: sodium bicarbonate bolus administration in neonates lacks supporting evidence, has documented risks including intracranial hemorrhage, and should not be used in neonatal resuscitation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.